Protalix Biotherapeutics Aktie
WKN: A2PWSL
ISIN: US74365A3095
Land: USA
Branche: Chemie, Pharma, Bio- & Medizintechnik
Sektor: Pharma
1,36 EUR 0,05 EUR 3,82 %
22:18:11 L&S RT
Komplette Navigation anzeigen

News und Analysen

EQS-News: Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment

EQS-News: Protalix BioTherapeautics Inc. Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment 30.11.2022 / 21:00 CET/CEST The issuer is solely responsible for ...weiterlesen

Jetzt neu: